# Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma

> **NCT01490203** · — · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 71 (actual)

## Conditions studied

- Carcinoma, Hepatocellular
- Liver Dysfunction

## Interventions

- **DRUG:** Gd-EOB-DTPA
- **DRUG:** Gd-EOB-DTPA
- **PROCEDURE:** MRI
- **PROCEDURE:** MRI

## Key facts

- **NCT ID:** NCT01490203
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-02
- **Final completion:** 2016-12
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2018-03-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01490203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01490203, "Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01490203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*